You have successfully logged out.
Company News
Newsroom
Stay up-to-date with our latest company news.
December 15, 2025
B. Braun Launches First-of-its-Kind Supply Assurance Program to Strengthen Supply Chain Resiliency and Support Uninterrupted Patient Care
We announced the launch of our Supply Assurance Program, a first-of-its-kind initiative designed to reinforce supply chain resiliency and protect patient care from disruption in the medical device and pharmaceutical sectors. By placing inventory closer to the point of care, B. Braun is helping healthcare providers access the products they need without any additional cost.
Read more
October 15, 2025
B. Braun Launches Midazolam in 0.8% Sodium Chloride Injection with Enhanced Safety and Usability Features
We announced the launch of Midazolam in 0.8% Sodium Chloride Injection in the U.S. market. The preservative-free injections will be offered in two strengths — 50 mg in 50 mL and 100 mg in 100 mL. Both strengths are packaged in IV bags that are not made with DEHP, PVC or natural rubber latex, placing a priority on patient and environmental safety.
Read moreSeptember 24, 2025
B. Braun Receives Nurse Approved Certification for Full IV Solutions Portfolio Not Made with DEHP or PVC, Plastic Irrigation Containers and Pip-Taz in DUPLEX®
We are proud to announce our entire IV Solutions portfolio not made with DEHP or PVC, Plastic Irrigation Containers, and Piperacillin and Tazobactam (Pip-Taz) in DUPLEX® Drug Delivery System have received the prestigious Nurse Approved Certification. This certification, awarded through the rigorous Nurse Quality Standards Index process, recognizes B. Braun’s commitment to excellence in usability, workflow integration and alignment with nursing practice needs.
Read more
Press release archive
B. Braun Launches First-of-its-Kind Supply Assurance Program to Strengthen Supply Chain Resiliency and Support Uninterrupted Patient Care
December 15, 2025
B. Braun Medical Inc. Launches Piperacillin and Tazobactam for Injection and Sodium Chloride Injection in the DUPLEX® Drug Delivery System
December 5, 2025
B. Braun Launches Midazolam in 0.8% Sodium Chloride Injection with Enhanced Safety and Usability Features
October 15, 2025
B. Braun Receives Nurse Approved Certification for Full IV Solutions Portfolio Not Made with DEHP or PVC, Plastic Irrigation Containers and Pip-Taz in DUPLEX®
September 24, 2025
B. Braun Launches Tromethamine Injection in EXCEL® IV Container
September 15, 2025
B. Braun SE Acquires True Digital Surgery
September 12, 2025
B. Braun Expands Heparin Sodium Injection Portfolio to Seven Heparin Premixed Sodium Injection Products
July 18, 2025
B. Braun Launches EZCOVER® Probe Cover Set for Improved Ultrasound Safety in Peripheral Nerve Block Procedures
April 14, 2025
B. Braun Launches Ready-to-Activate Cefazolin 3 Gram Pre-Mix in DUPLEX® Containers
March 24, 2025
B. Braun Launches First Ever Emergency Department-Specific Nerve Block Tray
February 18, 2025
B. Braun Launches Clik-FIX® Epidural/PNB Catheter Securement Device
January 21, 2025
B. Braun Takes Steps to Secure the Supply of Critical IV Fluids in the US
October 18, 2024
B. Braun Medical Receives FDA Clearance for Introcan Safety® 2 Deep Access IV Catheter
September 24, 2024
B. Braun Medical Announces First U.S. Conversion to NRFit® Connectors
July 24, 2024
B. Braun Launches Levetiracetam in Sodium Chloride Injection Portfolio
May 28, 2024
B. Braun and Orlando Health to Collaborate on Healthcare Innovation
March 5, 2024
B. Braun of America Appoints Two Executive Leadership Team Members to its Board of Directors
March 1, 2024
B. Braun Launches Heparin Sodium 2,000 Units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL)
February 13, 2024
Rob Albert appointed Chief Executive Officer of B. Braun of America Inc.
January 24, 2024
B. Braun Launches the CARESITE Micro™ Luer Access Device and Extension Sets
December 14, 2023
B. Braun of America Appoints Two Global Healthcare Leaders to its Board of Directors
October 27, 2023
B. Braun Announces Comprehensive Resources to Address Health Inequities in Vascular Access and Care
October 13, 2023
Braun Launches Introcan Safety® 2 IV Catheter with Multi-Access Blood Control
October 11, 2023
B. Braun Receives FDA Clearance for AQUAbase® nX Reverse Osmosis System
September 18, 2023
B. Braun Launches DoseTrac® Enterprise Infusion Management Software
June 1, 2023
B. Braun Launches Online e-University Platform for Healthcare Providers
March 7, 2023
B. Braun’s Space® Infusion Pump Systems Earn UL 2900-2-1 Certification
December 1, 2022
B. Braun and Lehigh Valley Health Network to Collaborate on Recycling Medical Plastics Waste
October 18, 2022
AVA, B. Braun Partnership Continues to Raise Standards for PIV Education and Training with Launch of New Certificate Course on Vascular Access
September 29, 2022
B. Braun Acquires Clik-FIX® Catheter Securement Devices from Starboard Medical
September 27, 2022
B. Braun Launches Introcan Safety® 2 IV Catheter with One-time Blood Control Designed to Make IV Access Safer for Clinicians
July 12, 2022
B. Braun and Massachusetts General Hospital to Collaborate on Healthcare Delivery Challenges
May 10, 2022
AVA, B. Braun Launch Second Fundamentals of Peripheral Intravenous Vascular Access Course
February 22, 2022
B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site
January 28, 2022
B. Braun Announces Nationwide Availability of Magnesium Sulfate Family of Products
December 8, 2021
B. Braun Medical Launches Next Generation OnGuard® 2 CSTD
December 2, 2021
B. Braun Launches CARESAFE™ IV Administration Sets With Optional AirStop
September 21, 2021
B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
June 30, 2021
B. Braun Receives the First and Only FDA Approval for Acetaminophen Injection in Multiple Doses
February 25, 2021
B. Braun Announces James Allen as New Chief Financial Officer
February 23, 2021
Information on Unauthorized Distribution of Introcan Safety® Catheters
February 3, 2021
B. Braun Infusomat® Space® Infusion Pump Receives 2021 Best in KLAS Award for Traditional Smart Pumps
February 2, 2021
Company statements
Media Relations
If you are a journalist and have questions about B. Braun or need any material which you cannot find in our newsroom, you are welcome to get in contact with us.
Allison Longenhagen
Director, Corporate Communications
References
1. Sartoretti T, Sartoretti E, Bucher C et al. Bacterial contamination of ultrasound probes in different radiological institutions before and after specific hygiene training: do we have a general hygienical problem? Eur Radiol. 2017 Oct;27(10):4181-4187
2. IQVIA Q4 All Injectables